The molecular markers of hemostatic activation on coronary artery disease

Thrombosis Research
T UlutinG Sultuybek

Abstract

Endothelial cells, circulating platelets, and proteins of the coagulation and fibrinolytic systems are known to contribute to the hemostatic processes. Various molecular markers of hemostatic alteration are found in increased amounts in the circulation during the activation of this process. In this study, we investigated serum lipoprotein (a) and plasma platelet factor 4, beta-thromboglobulin, thrombin-anthithrombin complex, fibrinopeptid A, D-dimer, tissue plasminogen activator, tissue plasminogen activator inhibitor, and fibronectin levels in patients with coronary artery disease. The levels of all these markers were found to be significantly higher as compared to the control group. Our findings suggest that patients with coronary artery disease have greater blood coagulability than controls, and the use of molecular markers has become greatly important in clinical practice.

References

Nov 27, 1992·The American Journal of Cardiology·A V Chobanian
Mar 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·J LoscalzoA M Scanu
Oct 1, 1990·American Journal of Clinical Pathology·V B ReddyH R Schumacher
Jan 1, 1986·Critical Reviews in Oncology/hematology·D Collen, H R Lijnen
Apr 1, 1988·Seminars in Thrombosis and Hemostasis·D Collen, I Juhan-Vague
Jul 1, 1987·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·V W van HinsberghD C Rijken
Apr 1, 1986·Seminars in Thrombosis and Hemostasis·S Balkuv-Ulutin
Oct 1, 1984·Seminars in Thrombosis and Hemostasis·H L MessmoreJ Fareed
Oct 1, 1983·Seminars in Thrombosis and Hemostasis·J M WalengaH L Messmore
Jan 1, 1980·Acta Medica Scandinavica. Supplementum·S StenmanA Vaheri
Jan 1, 1981·Atherosclerosis·G M KostnerG B Qunici
Jul 1, 1996·Thrombosis Research·S SüerG Sultuybek

❮ Previous
Next ❯

Citations

Jun 8, 2001·Thrombosis Research·C C CummingsV L Serebruany
Feb 2, 2010·Thrombosis Research·Lisa M MaurerDeane F Mosher
Feb 3, 2007·Journal of Thrombosis and Haemostasis : JTH·J P VavalleG A Stouffer
Jan 29, 2005·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Hakan EkmekciEmine Kokoglu

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Clinical Chemistry and Laboratory Medicine : CCLM
Ying ZhangFang Zheng
Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Hakan EkmekciEmine Kokoglu
Thrombosis and Haemostasis
B R Tomasini-Johansson, D F Mosher
© 2022 Meta ULC. All rights reserved